nodes	percent_of_prediction	percent_of_DWPC	metapath
Cisplatin—bone cancer—sarcoma	0.124	0.246	CtDrD
Cisplatin—testicular cancer—sarcoma	0.102	0.204	CtDrD
Cisplatin—germ cell cancer—sarcoma	0.0981	0.195	CtDrD
Cisplatin—peripheral nervous system neoplasm—sarcoma	0.0905	0.18	CtDrD
Cisplatin—lung cancer—sarcoma	0.0882	0.175	CtDrD
Cisplatin—ABCC6—Dactinomycin—sarcoma	0.0524	0.148	CbGbCtD
Cisplatin—GSTT1—Etoposide—sarcoma	0.0515	0.146	CbGbCtD
Cisplatin—GSTP1—Etoposide—sarcoma	0.0322	0.0912	CbGbCtD
Cisplatin—ABCC6—Etoposide—sarcoma	0.0296	0.0838	CbGbCtD
Cisplatin—NQO1—Doxorubicin—sarcoma	0.0241	0.0683	CbGbCtD
Cisplatin—ABCC6—Doxorubicin—sarcoma	0.0202	0.0572	CbGbCtD
Cisplatin—ABCC3—Vincristine—sarcoma	0.0155	0.0439	CbGbCtD
Cisplatin—CYP2B6—Thiotepa—sarcoma	0.0151	0.0429	CbGbCtD
Cisplatin—ABCC3—Etoposide—sarcoma	0.0142	0.0403	CbGbCtD
Cisplatin—XDH—Doxorubicin—sarcoma	0.0126	0.0357	CbGbCtD
Cisplatin—ABCG2—Dactinomycin—sarcoma	0.0103	0.0293	CbGbCtD
Cisplatin—ABCC3—Doxorubicin—sarcoma	0.00969	0.0275	CbGbCtD
Cisplatin—ABCG2—Mitoxantrone—sarcoma	0.00925	0.0262	CbGbCtD
Cisplatin—ABCC2—Vincristine—sarcoma	0.00704	0.02	CbGbCtD
Cisplatin—ABCC2—Etoposide—sarcoma	0.00645	0.0183	CbGbCtD
Cisplatin—PTGS2—Etoposide—sarcoma	0.00638	0.0181	CbGbCtD
Cisplatin—ABCG2—Vincristine—sarcoma	0.00637	0.0181	CbGbCtD
Cisplatin—ABCG2—Etoposide—sarcoma	0.00584	0.0165	CbGbCtD
Cisplatin—ABCC2—Doxorubicin—sarcoma	0.0044	0.0125	CbGbCtD
Cisplatin—ABCG2—Doxorubicin—sarcoma	0.00398	0.0113	CbGbCtD
Cisplatin—ABCB1—Dactinomycin—sarcoma	0.00373	0.0106	CbGbCtD
Cisplatin—ABCB1—Mitoxantrone—sarcoma	0.00334	0.00946	CbGbCtD
Cisplatin—CYP2B6—Doxorubicin—sarcoma	0.0028	0.00793	CbGbCtD
Cisplatin—ABCC6—dermis—sarcoma	0.00261	0.0635	CbGeAlD
Cisplatin—ABCB1—Vincristine—sarcoma	0.0023	0.00651	CbGbCtD
Cisplatin—ABCB1—Etoposide—sarcoma	0.0021	0.00596	CbGbCtD
Cisplatin—ABCB1—Doxorubicin—sarcoma	0.00144	0.00407	CbGbCtD
Cisplatin—BCHE—diaphragm—sarcoma	0.00129	0.0314	CbGeAlD
Cisplatin—ABCC6—Podofilox—Etoposide—sarcoma	0.00126	1	CbGdCrCtD
Cisplatin—ATP7A—endothelium—sarcoma	0.000868	0.0211	CbGeAlD
Cisplatin—PTGS2—periosteum—sarcoma	0.000573	0.0139	CbGeAlD
Cisplatin—MT1A—connective tissue—sarcoma	0.000569	0.0138	CbGeAlD
Cisplatin—SLC31A2—myometrium—sarcoma	0.000564	0.0137	CbGeAlD
Cisplatin—ATP7B—hematopoietic system—sarcoma	0.00053	0.0129	CbGeAlD
Cisplatin—SLC31A2—seminal vesicle—sarcoma	0.000509	0.0124	CbGeAlD
Cisplatin—ATP7A—myometrium—sarcoma	0.000497	0.0121	CbGeAlD
Cisplatin—MT2A—hematopoietic system—sarcoma	0.000492	0.012	CbGeAlD
Cisplatin—SLC31A2—hematopoietic system—sarcoma	0.000484	0.0118	CbGeAlD
Cisplatin—GSTT1—hematopoietic system—sarcoma	0.000482	0.0117	CbGeAlD
Cisplatin—MT2A—connective tissue—sarcoma	0.000474	0.0115	CbGeAlD
Cisplatin—MPO—endothelium—sarcoma	0.000466	0.0113	CbGeAlD
Cisplatin—PTGS2—leg—sarcoma	0.000457	0.0111	CbGeAlD
Cisplatin—ATP7A—seminal vesicle—sarcoma	0.000449	0.0109	CbGeAlD
Cisplatin—ABCC5—mammary gland—sarcoma	0.000436	0.0106	CbGeAlD
Cisplatin—SOD1—myometrium—sarcoma	0.000435	0.0106	CbGeAlD
Cisplatin—MT2A—skin of body—sarcoma	0.000428	0.0104	CbGeAlD
Cisplatin—SLC31A1—myometrium—sarcoma	0.000424	0.0103	CbGeAlD
Cisplatin—ATP7A—connective tissue—sarcoma	0.000411	0.00999	CbGeAlD
Cisplatin—NQO1—mammary gland—sarcoma	0.000408	0.00993	CbGeAlD
Cisplatin—PTGS2—hindlimb—sarcoma	0.000408	0.00992	CbGeAlD
Cisplatin—ATP7B—cardiac atrium—sarcoma	0.000402	0.00978	CbGeAlD
Cisplatin—PTGS2—cartilage tissue—sarcoma	0.000401	0.00977	CbGeAlD
Cisplatin—ATP7B—uterus—sarcoma	0.0004	0.00973	CbGeAlD
Cisplatin—SOD1—seminal vesicle—sarcoma	0.000393	0.00955	CbGeAlD
Cisplatin—ABCC6—hematopoietic system—sarcoma	0.000391	0.00951	CbGeAlD
Cisplatin—SLC31A1—seminal vesicle—sarcoma	0.000383	0.00931	CbGeAlD
Cisplatin—ABCC6—connective tissue—sarcoma	0.000377	0.00916	CbGeAlD
Cisplatin—GSTM1—hematopoietic system—sarcoma	0.000355	0.00863	CbGeAlD
Cisplatin—PTGS2—appendage—sarcoma	0.00035	0.00851	CbGeAlD
Cisplatin—MT2A—lymphoid tissue—sarcoma	0.000347	0.00843	CbGeAlD
Cisplatin—GSTM1—connective tissue—sarcoma	0.000342	0.00831	CbGeAlD
Cisplatin—GSTT1—lymphoid tissue—sarcoma	0.000339	0.00825	CbGeAlD
Cisplatin—SOD1—smooth muscle tissue—sarcoma	0.000329	0.00799	CbGeAlD
Cisplatin—MT1A—testis—sarcoma	0.000324	0.00788	CbGeAlD
Cisplatin—SLC31A2—tendon—sarcoma	0.00032	0.00779	CbGeAlD
Cisplatin—SLC31A2—bone marrow—sarcoma	0.00031	0.00755	CbGeAlD
Cisplatin—GSTM1—skin of body—sarcoma	0.000309	0.00751	CbGeAlD
Cisplatin—MT1A—liver—sarcoma	0.000306	0.00745	CbGeAlD
Cisplatin—ATP7B—testis—sarcoma	0.00029	0.00706	CbGeAlD
Cisplatin—NQO1—myometrium—sarcoma	0.00029	0.00705	CbGeAlD
Cisplatin—SOD1—cardiac atrium—sarcoma	0.000283	0.00689	CbGeAlD
Cisplatin—ATP7A—tendon—sarcoma	0.000282	0.00686	CbGeAlD
Cisplatin—CYP4A11—liver—sarcoma	0.000282	0.00686	CbGeAlD
Cisplatin—SOD1—uterus—sarcoma	0.000282	0.00686	CbGeAlD
Cisplatin—SLC31A1—cardiac atrium—sarcoma	0.000276	0.00672	CbGeAlD
Cisplatin—ATP7B—liver—sarcoma	0.000274	0.00667	CbGeAlD
Cisplatin—ATP7A—bone marrow—sarcoma	0.000273	0.00665	CbGeAlD
Cisplatin—MT2A—testis—sarcoma	0.00027	0.00656	CbGeAlD
Cisplatin—SLC31A2—testis—sarcoma	0.000265	0.00645	CbGeAlD
Cisplatin—NQO1—seminal vesicle—sarcoma	0.000262	0.00637	CbGeAlD
Cisplatin—GSTP1—myometrium—sarcoma	0.000259	0.0063	CbGeAlD
Cisplatin—MT2A—liver—sarcoma	0.000255	0.00621	CbGeAlD
Cisplatin—SLC31A2—liver—sarcoma	0.000251	0.0061	CbGeAlD
Cisplatin—GSTM1—lymphoid tissue—sarcoma	0.00025	0.00608	CbGeAlD
Cisplatin—GSTT1—liver—sarcoma	0.00025	0.00607	CbGeAlD
Cisplatin—GSTP1—embryo—sarcoma	0.000249	0.00606	CbGeAlD
Cisplatin—NQO1—hematopoietic system—sarcoma	0.000249	0.00605	CbGeAlD
Cisplatin—SOD1—tendon—sarcoma	0.000247	0.00601	CbGeAlD
Cisplatin—SLC31A1—tendon—sarcoma	0.000241	0.00585	CbGeAlD
Cisplatin—NQO1—connective tissue—sarcoma	0.00024	0.00583	CbGeAlD
Cisplatin—SOD1—bone marrow—sarcoma	0.000239	0.00582	CbGeAlD
Cisplatin—MT1A—lymph node—sarcoma	0.000235	0.00571	CbGeAlD
Cisplatin—GSTP1—seminal vesicle—sarcoma	0.000234	0.00569	CbGeAlD
Cisplatin—ATP7A—testis—sarcoma	0.000234	0.00568	CbGeAlD
Cisplatin—SLC31A1—bone marrow—sarcoma	0.000233	0.00567	CbGeAlD
Cisplatin—MPO—hematopoietic system—sarcoma	0.000229	0.00556	CbGeAlD
Cisplatin—ABCC3—hematopoietic system—sarcoma	0.000223	0.00543	CbGeAlD
Cisplatin—GSTP1—hematopoietic system—sarcoma	0.000222	0.00541	CbGeAlD
Cisplatin—ATP7A—liver—sarcoma	0.000221	0.00537	CbGeAlD
Cisplatin—MPO—connective tissue—sarcoma	0.00022	0.00536	CbGeAlD
Cisplatin—NQO1—smooth muscle tissue—sarcoma	0.000219	0.00533	CbGeAlD
Cisplatin—NQO1—skin of body—sarcoma	0.000216	0.00526	CbGeAlD
Cisplatin—GSTP1—connective tissue—sarcoma	0.000214	0.00521	CbGeAlD
Cisplatin—PTGS2—endothelium—sarcoma	0.000211	0.00514	CbGeAlD
Cisplatin—ATP7B—lymph node—sarcoma	0.00021	0.00512	CbGeAlD
Cisplatin—SOD1—testis—sarcoma	0.000204	0.00497	CbGeAlD
Cisplatin—ABCC6—liver—sarcoma	0.000203	0.00493	CbGeAlD
Cisplatin—ABCC5—cardiac atrium—sarcoma	0.000202	0.00491	CbGeAlD
Cisplatin—SLC31A1—testis—sarcoma	0.000199	0.00485	CbGeAlD
Cisplatin—MPO—skin of body—sarcoma	0.000199	0.00484	CbGeAlD
Cisplatin—GSTP1—smooth muscle tissue—sarcoma	0.000196	0.00476	CbGeAlD
Cisplatin—CYP2C9—mammary gland—sarcoma	0.000195	0.00475	CbGeAlD
Cisplatin—GSTM1—testis—sarcoma	0.000195	0.00473	CbGeAlD
Cisplatin—SOD1—liver—sarcoma	0.000193	0.0047	CbGeAlD
Cisplatin—GSTP1—skin of body—sarcoma	0.000193	0.0047	CbGeAlD
Cisplatin—SLC31A2—lymph node—sarcoma	0.000192	0.00468	CbGeAlD
Cisplatin—SLC31A1—liver—sarcoma	0.000188	0.00458	CbGeAlD
Cisplatin—NQO1—uterus—sarcoma	0.000188	0.00457	CbGeAlD
Cisplatin—XDH—liver—sarcoma	0.000186	0.00453	CbGeAlD
Cisplatin—GSTM1—liver—sarcoma	0.000184	0.00447	CbGeAlD
Cisplatin—ABCC5—tendon—sarcoma	0.000176	0.00428	CbGeAlD
Cisplatin—ABCC5—bone marrow—sarcoma	0.00017	0.00415	CbGeAlD
Cisplatin—ATP7A—lymph node—sarcoma	0.000169	0.00412	CbGeAlD
Cisplatin—GSTP1—cardiac atrium—sarcoma	0.000169	0.00411	CbGeAlD
Cisplatin—GSTP1—uterus—sarcoma	0.000168	0.00408	CbGeAlD
Cisplatin—NQO1—tendon—sarcoma	0.000165	0.004	CbGeAlD
Cisplatin—MPO—lymphoid tissue—sarcoma	0.000161	0.00392	CbGeAlD
Cisplatin—BCHE—myometrium—sarcoma	0.000157	0.00381	CbGeAlD
Cisplatin—GSTP1—lymphoid tissue—sarcoma	0.000157	0.00381	CbGeAlD
Cisplatin—ABCG2—myometrium—sarcoma	0.000152	0.00369	CbGeAlD
Cisplatin—SOD1—lymph node—sarcoma	0.000148	0.00361	CbGeAlD
Cisplatin—GSTP1—tendon—sarcoma	0.000147	0.00358	CbGeAlD
Cisplatin—MPO—bone marrow—sarcoma	0.000147	0.00357	CbGeAlD
Cisplatin—ABCC5—testis—sarcoma	0.000146	0.00354	CbGeAlD
Cisplatin—SLC31A1—lymph node—sarcoma	0.000144	0.00351	CbGeAlD
Cisplatin—GSTP1—bone marrow—sarcoma	0.000143	0.00347	CbGeAlD
Cisplatin—BCHE—seminal vesicle—sarcoma	0.000142	0.00345	CbGeAlD
Cisplatin—GSTM1—lymph node—sarcoma	0.000141	0.00343	CbGeAlD
Cisplatin—ABCC5—liver—sarcoma	0.000138	0.00335	CbGeAlD
Cisplatin—ABCG2—seminal vesicle—sarcoma	0.000137	0.00333	CbGeAlD
Cisplatin—NQO1—testis—sarcoma	0.000136	0.00332	CbGeAlD
Cisplatin—BCHE—hematopoietic system—sarcoma	0.000135	0.00327	CbGeAlD
Cisplatin—NQO1—liver—sarcoma	0.000129	0.00314	CbGeAlD
Cisplatin—MPO—testis—sarcoma	0.000125	0.00305	CbGeAlD
Cisplatin—ABCC3—testis—sarcoma	0.000122	0.00298	CbGeAlD
Cisplatin—GSTP1—testis—sarcoma	0.000122	0.00296	CbGeAlD
Cisplatin—PTGS2—myometrium—sarcoma	0.000121	0.00294	CbGeAlD
Cisplatin—CYP2B6—hematopoietic system—sarcoma	0.00012	0.00292	CbGeAlD
Cisplatin—CYP2C9—hematopoietic system—sarcoma	0.000119	0.00289	CbGeAlD
Cisplatin—BCHE—smooth muscle tissue—sarcoma	0.000119	0.00288	CbGeAlD
Cisplatin—MPO—liver—sarcoma	0.000118	0.00288	CbGeAlD
Cisplatin—ABCC2—tendon—sarcoma	0.000118	0.00287	CbGeAlD
Cisplatin—BCHE—skin of body—sarcoma	0.000117	0.00285	CbGeAlD
Cisplatin—PTGS2—embryo—sarcoma	0.000116	0.00283	CbGeAlD
Cisplatin—ABCC3—liver—sarcoma	0.000116	0.00281	CbGeAlD
Cisplatin—GSTP1—liver—sarcoma	0.000115	0.0028	CbGeAlD
Cisplatin—PTGS2—seminal vesicle—sarcoma	0.000109	0.00265	CbGeAlD
Cisplatin—ABCC5—lymph node—sarcoma	0.000106	0.00257	CbGeAlD
Cisplatin—CYP2B6—skin of body—sarcoma	0.000104	0.00254	CbGeAlD
Cisplatin—PTGS2—hematopoietic system—sarcoma	0.000104	0.00252	CbGeAlD
Cisplatin—BCHE—cardiac atrium—sarcoma	0.000102	0.00249	CbGeAlD
Cisplatin—BCHE—uterus—sarcoma	0.000102	0.00247	CbGeAlD
Cisplatin—PTGS2—connective tissue—sarcoma	9.99e-05	0.00243	CbGeAlD
Cisplatin—NQO1—lymph node—sarcoma	9.88e-05	0.0024	CbGeAlD
Cisplatin—ABCG2—uterus—sarcoma	9.83e-05	0.00239	CbGeAlD
Cisplatin—ABCC2—testis—sarcoma	9.78e-05	0.00238	CbGeAlD
Cisplatin—ABCC2—liver—sarcoma	9.24e-05	0.00225	CbGeAlD
Cisplatin—PTGS2—smooth muscle tissue—sarcoma	9.13e-05	0.00222	CbGeAlD
Cisplatin—MPO—lymph node—sarcoma	9.09e-05	0.00221	CbGeAlD
Cisplatin—PTGS2—skin of body—sarcoma	9.02e-05	0.00219	CbGeAlD
Cisplatin—ABCC3—lymph node—sarcoma	8.87e-05	0.00216	CbGeAlD
Cisplatin—GSTP1—lymph node—sarcoma	8.83e-05	0.00215	CbGeAlD
Cisplatin—BCHE—bone marrow—sarcoma	8.63e-05	0.0021	CbGeAlD
Cisplatin—Musculoskeletal discomfort—Thiotepa—sarcoma	8.47e-05	0.00119	CcSEcCtD
Cisplatin—CYP2B6—lymphoid tissue—sarcoma	8.45e-05	0.00206	CbGeAlD
Cisplatin—Musculoskeletal discomfort—Dactinomycin—sarcoma	8.4e-05	0.00119	CcSEcCtD
Cisplatin—Cardiac failure congestive—Epirubicin—sarcoma	8.39e-05	0.00118	CcSEcCtD
Cisplatin—Myalgia—Mitoxantrone—sarcoma	8.37e-05	0.00118	CcSEcCtD
Cisplatin—Paraesthesia—Thiotepa—sarcoma	8.34e-05	0.00118	CcSEcCtD
Cisplatin—Anxiety—Mitoxantrone—sarcoma	8.34e-05	0.00118	CcSEcCtD
Cisplatin—ABCG2—bone marrow—sarcoma	8.34e-05	0.00203	CbGeAlD
Cisplatin—Alopecia—Etoposide—sarcoma	8.3e-05	0.00117	CcSEcCtD
Cisplatin—Discomfort—Mitoxantrone—sarcoma	8.27e-05	0.00117	CcSEcCtD
Cisplatin—Renal failure acute—Epirubicin—sarcoma	8.25e-05	0.00116	CcSEcCtD
Cisplatin—Anaphylactic shock—Vincristine—sarcoma	8.24e-05	0.00116	CcSEcCtD
Cisplatin—Oedema—Vincristine—sarcoma	8.24e-05	0.00116	CcSEcCtD
Cisplatin—ABCG2—Imatinib Resistance in Chronic Myeloid Leukemia—PDGFRB—sarcoma	8.21e-05	0.00265	CbGpPWpGaD
Cisplatin—Infection—Vincristine—sarcoma	8.19e-05	0.00115	CcSEcCtD
Cisplatin—Phlebitis—Doxorubicin—sarcoma	8.18e-05	0.00115	CcSEcCtD
Cisplatin—SOD1—AGE/RAGE pathway—SRC—sarcoma	8.16e-05	0.00263	CbGpPWpGaD
Cisplatin—MPO—Folate Metabolism—IL2—sarcoma	8.16e-05	0.00263	CbGpPWpGaD
Cisplatin—PTGS2—C-MYB transcription factor network—CD34—sarcoma	8.12e-05	0.00262	CbGpPWpGaD
Cisplatin—PTGS2—C-MYB transcription factor network—MYOD1—sarcoma	8.12e-05	0.00262	CbGpPWpGaD
Cisplatin—NQO1—Aryl Hydrocarbon Receptor—EGFR—sarcoma	8.12e-05	0.00262	CbGpPWpGaD
Cisplatin—NQO1—Aryl Hydrocarbon Receptor Pathway—EGFR—sarcoma	8.12e-05	0.00262	CbGpPWpGaD
Cisplatin—ABCG2—Imatinib Resistance in Chronic Myeloid Leukemia—PDGFRA—sarcoma	8.08e-05	0.00261	CbGpPWpGaD
Cisplatin—Nervous system disorder—Vincristine—sarcoma	8.08e-05	0.00114	CcSEcCtD
Cisplatin—Decreased appetite—Thiotepa—sarcoma	8.08e-05	0.00114	CcSEcCtD
Cisplatin—Thrombocytopenia—Vincristine—sarcoma	8.07e-05	0.00114	CcSEcCtD
Cisplatin—Anaphylactic shock—Mitoxantrone—sarcoma	8.03e-05	0.00113	CcSEcCtD
Cisplatin—Oedema—Mitoxantrone—sarcoma	8.03e-05	0.00113	CcSEcCtD
Cisplatin—Gastrointestinal disorder—Thiotepa—sarcoma	8.02e-05	0.00113	CcSEcCtD
Cisplatin—Decreased appetite—Dactinomycin—sarcoma	8.02e-05	0.00113	CcSEcCtD
Cisplatin—PTGS2—Quercetin and Nf-kB/ AP-1 Induced Cell Apoptosis—JUN—sarcoma	8.01e-05	0.00259	CbGpPWpGaD
Cisplatin—Infection—Mitoxantrone—sarcoma	7.97e-05	0.00112	CcSEcCtD
Cisplatin—Hyperhidrosis—Vincristine—sarcoma	7.97e-05	0.00112	CcSEcCtD
Cisplatin—Pain—Thiotepa—sarcoma	7.95e-05	0.00112	CcSEcCtD
Cisplatin—Pain—Dactinomycin—sarcoma	7.89e-05	0.00111	CcSEcCtD
Cisplatin—Anaphylactoid reaction—Epirubicin—sarcoma	7.87e-05	0.00111	CcSEcCtD
Cisplatin—Muscle spasms—Etoposide—sarcoma	7.86e-05	0.00111	CcSEcCtD
Cisplatin—Thrombocytopenia—Mitoxantrone—sarcoma	7.86e-05	0.00111	CcSEcCtD
Cisplatin—Anorexia—Vincristine—sarcoma	7.85e-05	0.00111	CcSEcCtD
Cisplatin—PTGS2—uterus—sarcoma	7.83e-05	0.00191	CbGeAlD
Cisplatin—Tachycardia—Mitoxantrone—sarcoma	7.83e-05	0.0011	CcSEcCtD
Cisplatin—Skin disorder—Mitoxantrone—sarcoma	7.8e-05	0.0011	CcSEcCtD
Cisplatin—Cerebrovascular accident—Epirubicin—sarcoma	7.77e-05	0.0011	CcSEcCtD
Cisplatin—Cardiac failure congestive—Doxorubicin—sarcoma	7.77e-05	0.0011	CcSEcCtD
Cisplatin—Hyperhidrosis—Mitoxantrone—sarcoma	7.76e-05	0.00109	CcSEcCtD
Cisplatin—GSTM1—C-MYB transcription factor network—CCND1—sarcoma	7.71e-05	0.00249	CbGpPWpGaD
Cisplatin—Hypotension—Vincristine—sarcoma	7.7e-05	0.00109	CcSEcCtD
Cisplatin—NQO1—Aryl Hydrocarbon Receptor—KRAS—sarcoma	7.67e-05	0.00247	CbGpPWpGaD
Cisplatin—Feeling abnormal—Thiotepa—sarcoma	7.66e-05	0.00108	CcSEcCtD
Cisplatin—Anorexia—Mitoxantrone—sarcoma	7.65e-05	0.00108	CcSEcCtD
Cisplatin—ABCC5—Fluoropyrimidine Activity—TP53—sarcoma	7.64e-05	0.00247	CbGpPWpGaD
Cisplatin—Hyponatraemia—Epirubicin—sarcoma	7.64e-05	0.00108	CcSEcCtD
Cisplatin—SOD1—Hemostasis—ANGPT2—sarcoma	7.64e-05	0.00247	CbGpPWpGaD
Cisplatin—Renal failure acute—Doxorubicin—sarcoma	7.63e-05	0.00108	CcSEcCtD
Cisplatin—Gastrointestinal haemorrhage—Epirubicin—sarcoma	7.61e-05	0.00107	CcSEcCtD
Cisplatin—Feeling abnormal—Dactinomycin—sarcoma	7.6e-05	0.00107	CcSEcCtD
Cisplatin—Ill-defined disorder—Etoposide—sarcoma	7.59e-05	0.00107	CcSEcCtD
Cisplatin—Anaemia—Etoposide—sarcoma	7.56e-05	0.00107	CcSEcCtD
Cisplatin—Musculoskeletal discomfort—Vincristine—sarcoma	7.51e-05	0.00106	CcSEcCtD
Cisplatin—Hypotension—Mitoxantrone—sarcoma	7.5e-05	0.00106	CcSEcCtD
Cisplatin—SOD1—Validated nuclear estrogen receptor alpha network—MYC—sarcoma	7.49e-05	0.00242	CbGpPWpGaD
Cisplatin—ABCB1—myometrium—sarcoma	7.47e-05	0.00182	CbGeAlD
Cisplatin—Paraesthesia—Vincristine—sarcoma	7.4e-05	0.00104	CcSEcCtD
Cisplatin—BCHE—testis—sarcoma	7.38e-05	0.00179	CbGeAlD
Cisplatin—Malaise—Etoposide—sarcoma	7.38e-05	0.00104	CcSEcCtD
Cisplatin—Face oedema—Epirubicin—sarcoma	7.35e-05	0.00104	CcSEcCtD
Cisplatin—Body temperature increased—Thiotepa—sarcoma	7.35e-05	0.00104	CcSEcCtD
Cisplatin—Leukopenia—Etoposide—sarcoma	7.32e-05	0.00103	CcSEcCtD
Cisplatin—Musculoskeletal discomfort—Mitoxantrone—sarcoma	7.31e-05	0.00103	CcSEcCtD
Cisplatin—PTGS2—lymphoid tissue—sarcoma	7.3e-05	0.00178	CbGeAlD
Cisplatin—Body temperature increased—Dactinomycin—sarcoma	7.29e-05	0.00103	CcSEcCtD
Cisplatin—Anaphylactoid reaction—Doxorubicin—sarcoma	7.28e-05	0.00103	CcSEcCtD
Cisplatin—SOD1—Copper homeostasis—TP53—sarcoma	7.27e-05	0.00234	CbGpPWpGaD
Cisplatin—Paraesthesia—Mitoxantrone—sarcoma	7.21e-05	0.00102	CcSEcCtD
Cisplatin—Cerebrovascular accident—Doxorubicin—sarcoma	7.19e-05	0.00101	CcSEcCtD
Cisplatin—ABCB1—embryo—sarcoma	7.19e-05	0.00175	CbGeAlD
Cisplatin—Decreased appetite—Vincristine—sarcoma	7.16e-05	0.00101	CcSEcCtD
Cisplatin—Dyspnoea—Mitoxantrone—sarcoma	7.15e-05	0.00101	CcSEcCtD
Cisplatin—SOD1—AGE/RAGE pathway—EGFR—sarcoma	7.15e-05	0.00231	CbGpPWpGaD
Cisplatin—Blood creatinine increased—Epirubicin—sarcoma	7.13e-05	0.00101	CcSEcCtD
Cisplatin—ABCG2—testis—sarcoma	7.13e-05	0.00173	CbGeAlD
Cisplatin—Gastrointestinal disorder—Vincristine—sarcoma	7.11e-05	0.001	CcSEcCtD
Cisplatin—ABCC5—Carbohydrate metabolism—ENO2—sarcoma	7.09e-05	0.00229	CbGpPWpGaD
Cisplatin—Convulsion—Etoposide—sarcoma	7.09e-05	0.001	CcSEcCtD
Cisplatin—ABCC2—lymph node—sarcoma	7.09e-05	0.00172	CbGeAlD
Cisplatin—Dehydration—Epirubicin—sarcoma	7.08e-05	0.000999	CcSEcCtD
Cisplatin—Hyponatraemia—Doxorubicin—sarcoma	7.07e-05	0.000998	CcSEcCtD
Cisplatin—Pain—Vincristine—sarcoma	7.05e-05	0.000994	CcSEcCtD
Cisplatin—Gastrointestinal haemorrhage—Doxorubicin—sarcoma	7.04e-05	0.000994	CcSEcCtD
Cisplatin—PTGS2—Quercetin and Nf-kB/ AP-1 Induced Cell Apoptosis—VEGFA—sarcoma	7e-05	0.00226	CbGpPWpGaD
Cisplatin—Decreased appetite—Mitoxantrone—sarcoma	6.98e-05	0.000984	CcSEcCtD
Cisplatin—BCHE—liver—sarcoma	6.97e-05	0.0017	CbGeAlD
Cisplatin—Orthostatic hypotension—Epirubicin—sarcoma	6.95e-05	0.000981	CcSEcCtD
Cisplatin—Hypokalaemia—Epirubicin—sarcoma	6.93e-05	0.000977	CcSEcCtD
Cisplatin—Unspecified disorder of skin and subcutaneous tissue—Etoposide—sarcoma	6.92e-05	0.000975	CcSEcCtD
Cisplatin—Discomfort—Etoposide—sarcoma	6.88e-05	0.00097	CcSEcCtD
Cisplatin—Breast disorder—Epirubicin—sarcoma	6.88e-05	0.00097	CcSEcCtD
Cisplatin—PTGS2—tendon—sarcoma	6.86e-05	0.00167	CbGeAlD
Cisplatin—Pain—Mitoxantrone—sarcoma	6.86e-05	0.000968	CcSEcCtD
Cisplatin—Aspartate aminotransferase increased—Epirubicin—sarcoma	6.86e-05	0.000967	CcSEcCtD
Cisplatin—Hypersensitivity—Thiotepa—sarcoma	6.85e-05	0.000966	CcSEcCtD
Cisplatin—SOD1—Platelet degranulation—VEGFA—sarcoma	6.81e-05	0.0022	CbGpPWpGaD
Cisplatin—Nasopharyngitis—Epirubicin—sarcoma	6.81e-05	0.00096	CcSEcCtD
Cisplatin—Face oedema—Doxorubicin—sarcoma	6.8e-05	0.000959	CcSEcCtD
Cisplatin—Hypersensitivity—Dactinomycin—sarcoma	6.8e-05	0.000958	CcSEcCtD
Cisplatin—ABCB1—seminal vesicle—sarcoma	6.75e-05	0.00164	CbGeAlD
Cisplatin—ABCG2—liver—sarcoma	6.74e-05	0.00164	CbGeAlD
Cisplatin—ABCB1—HIF-1-alpha transcription factor network—NPM1—sarcoma	6.72e-05	0.00217	CbGpPWpGaD
Cisplatin—Anaphylactic shock—Etoposide—sarcoma	6.68e-05	0.000941	CcSEcCtD
Cisplatin—Asthenia—Thiotepa—sarcoma	6.67e-05	0.00094	CcSEcCtD
Cisplatin—PTGS2—bone marrow—sarcoma	6.65e-05	0.00162	CbGeAlD
Cisplatin—GSTM1—C-MYB transcription factor network—NRAS—sarcoma	6.64e-05	0.00214	CbGpPWpGaD
Cisplatin—Infection—Etoposide—sarcoma	6.63e-05	0.000935	CcSEcCtD
Cisplatin—Asthenia—Dactinomycin—sarcoma	6.62e-05	0.000933	CcSEcCtD
Cisplatin—Feeling abnormal—Mitoxantrone—sarcoma	6.61e-05	0.000933	CcSEcCtD
Cisplatin—Blood creatinine increased—Doxorubicin—sarcoma	6.6e-05	0.000931	CcSEcCtD
Cisplatin—CYP2B6—testis—sarcoma	6.58e-05	0.0016	CbGeAlD
Cisplatin—MPO—C-MYB transcription factor network—CCND1—sarcoma	6.56e-05	0.00212	CbGpPWpGaD
Cisplatin—Dehydration—Doxorubicin—sarcoma	6.55e-05	0.000924	CcSEcCtD
Cisplatin—Thrombocytopenia—Etoposide—sarcoma	6.54e-05	0.000922	CcSEcCtD
Cisplatin—NQO1—Aryl Hydrocarbon Receptor—HRAS—sarcoma	6.52e-05	0.0021	CbGpPWpGaD
Cisplatin—Tachycardia—Etoposide—sarcoma	6.51e-05	0.000919	CcSEcCtD
Cisplatin—Body temperature increased—Vincristine—sarcoma	6.51e-05	0.000919	CcSEcCtD
Cisplatin—SOD1—Response to elevated platelet cytosolic Ca2+—VEGFA—sarcoma	6.49e-05	0.00209	CbGpPWpGaD
Cisplatin—Skin disorder—Etoposide—sarcoma	6.48e-05	0.000914	CcSEcCtD
Cisplatin—PTGS2—Selenium Micronutrient Network—HBA1—sarcoma	6.48e-05	0.00209	CbGpPWpGaD
Cisplatin—Hyperhidrosis—Etoposide—sarcoma	6.45e-05	0.00091	CcSEcCtD
Cisplatin—Pancreatitis—Epirubicin—sarcoma	6.45e-05	0.00091	CcSEcCtD
Cisplatin—Orthostatic hypotension—Doxorubicin—sarcoma	6.43e-05	0.000907	CcSEcCtD
Cisplatin—ABCB1—hematopoietic system—sarcoma	6.42e-05	0.00156	CbGeAlD
Cisplatin—Hypokalaemia—Doxorubicin—sarcoma	6.41e-05	0.000904	CcSEcCtD
Cisplatin—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—FLT1—sarcoma	6.38e-05	0.00206	CbGpPWpGaD
Cisplatin—Breast disorder—Doxorubicin—sarcoma	6.37e-05	0.000898	CcSEcCtD
Cisplatin—Anorexia—Etoposide—sarcoma	6.36e-05	0.000897	CcSEcCtD
Cisplatin—Diarrhoea—Thiotepa—sarcoma	6.36e-05	0.000897	CcSEcCtD
Cisplatin—Body temperature increased—Mitoxantrone—sarcoma	6.34e-05	0.000895	CcSEcCtD
Cisplatin—Aspartate aminotransferase increased—Doxorubicin—sarcoma	6.34e-05	0.000895	CcSEcCtD
Cisplatin—Diarrhoea—Dactinomycin—sarcoma	6.31e-05	0.00089	CcSEcCtD
Cisplatin—Nasopharyngitis—Doxorubicin—sarcoma	6.3e-05	0.000888	CcSEcCtD
Cisplatin—ABCG2—Imatinib Resistance in Chronic Myeloid Leukemia—KIT—sarcoma	6.27e-05	0.00202	CbGpPWpGaD
Cisplatin—ABCB1—Constitutive Androstane Receptor Pathway—FOXO1—sarcoma	6.25e-05	0.00202	CbGpPWpGaD
Cisplatin—Pancytopenia—Epirubicin—sarcoma	6.25e-05	0.000881	CcSEcCtD
Cisplatin—Hypotension—Etoposide—sarcoma	6.24e-05	0.00088	CcSEcCtD
Cisplatin—CYP2B6—liver—sarcoma	6.22e-05	0.00151	CbGeAlD
Cisplatin—GSTM1—C-MYB transcription factor network—MYC—sarcoma	6.19e-05	0.002	CbGpPWpGaD
Cisplatin—CYP2C9—liver—sarcoma	6.16e-05	0.0015	CbGeAlD
Cisplatin—SOD1—Hemostasis—VEGFC—sarcoma	6.13e-05	0.00198	CbGpPWpGaD
Cisplatin—PTGS2—S1P1 pathway—VEGFA—sarcoma	6.1e-05	0.00197	CbGpPWpGaD
Cisplatin—Hypersensitivity—Vincristine—sarcoma	6.07e-05	0.000856	CcSEcCtD
Cisplatin—SOD1—Folate Metabolism—TP53—sarcoma	6.01e-05	0.00194	CbGpPWpGaD
Cisplatin—Paraesthesia—Etoposide—sarcoma	5.99e-05	0.000845	CcSEcCtD
Cisplatin—Pancreatitis—Doxorubicin—sarcoma	5.97e-05	0.000842	CcSEcCtD
Cisplatin—PTGS2—Signaling mediated by p38-alpha and p38-beta—CREB1—sarcoma	5.96e-05	0.00192	CbGpPWpGaD
Cisplatin—Dyspnoea—Etoposide—sarcoma	5.95e-05	0.000839	CcSEcCtD
Cisplatin—Hypersensitivity—Mitoxantrone—sarcoma	5.91e-05	0.000834	CcSEcCtD
Cisplatin—Asthenia—Vincristine—sarcoma	5.91e-05	0.000834	CcSEcCtD
Cisplatin—Vomiting—Thiotepa—sarcoma	5.91e-05	0.000833	CcSEcCtD
Cisplatin—Vomiting—Dactinomycin—sarcoma	5.86e-05	0.000827	CcSEcCtD
Cisplatin—Rash—Thiotepa—sarcoma	5.86e-05	0.000826	CcSEcCtD
Cisplatin—Dermatitis—Thiotepa—sarcoma	5.85e-05	0.000826	CcSEcCtD
Cisplatin—CYP2C9—Constitutive Androstane Receptor Pathway—FOXO1—sarcoma	5.84e-05	0.00189	CbGpPWpGaD
Cisplatin—Rash—Dactinomycin—sarcoma	5.82e-05	0.00082	CcSEcCtD
Cisplatin—Decreased appetite—Etoposide—sarcoma	5.8e-05	0.000818	CcSEcCtD
Cisplatin—Pancytopenia—Doxorubicin—sarcoma	5.78e-05	0.000815	CcSEcCtD
Cisplatin—Renal failure—Epirubicin—sarcoma	5.77e-05	0.000813	CcSEcCtD
Cisplatin—Gastrointestinal disorder—Etoposide—sarcoma	5.76e-05	0.000813	CcSEcCtD
Cisplatin—Asthenia—Mitoxantrone—sarcoma	5.76e-05	0.000812	CcSEcCtD
Cisplatin—Neuropathy peripheral—Epirubicin—sarcoma	5.75e-05	0.000811	CcSEcCtD
Cisplatin—ATP7A—Cellular responses to stress—MDM2—sarcoma	5.73e-05	0.00185	CbGpPWpGaD
Cisplatin—Stomatitis—Epirubicin—sarcoma	5.72e-05	0.000807	CcSEcCtD
Cisplatin—GSTM1—C-MYB transcription factor network—KRAS—sarcoma	5.72e-05	0.00184	CbGpPWpGaD
Cisplatin—Pain—Etoposide—sarcoma	5.71e-05	0.000805	CcSEcCtD
Cisplatin—Conjunctivitis—Epirubicin—sarcoma	5.7e-05	0.000804	CcSEcCtD
Cisplatin—MPO—C-MYB transcription factor network—NRAS—sarcoma	5.65e-05	0.00182	CbGpPWpGaD
Cisplatin—Diarrhoea—Vincristine—sarcoma	5.64e-05	0.000795	CcSEcCtD
Cisplatin—ABCC3—Fluoropyrimidine Activity—TP53—sarcoma	5.64e-05	0.00182	CbGpPWpGaD
Cisplatin—MT2A—Immune System—CD34—sarcoma	5.58e-05	0.0018	CbGpPWpGaD
Cisplatin—Hepatobiliary disease—Epirubicin—sarcoma	5.55e-05	0.000783	CcSEcCtD
Cisplatin—Nausea—Thiotepa—sarcoma	5.52e-05	0.000779	CcSEcCtD
Cisplatin—Feeling abnormal—Etoposide—sarcoma	5.5e-05	0.000776	CcSEcCtD
Cisplatin—Diarrhoea—Mitoxantrone—sarcoma	5.49e-05	0.000774	CcSEcCtD
Cisplatin—Nausea—Dactinomycin—sarcoma	5.48e-05	0.000773	CcSEcCtD
Cisplatin—PTGS2—liver—sarcoma	5.37e-05	0.00131	CbGeAlD
Cisplatin—Bradycardia—Epirubicin—sarcoma	5.36e-05	0.000756	CcSEcCtD
Cisplatin—BCHE—lymph node—sarcoma	5.35e-05	0.0013	CbGeAlD
Cisplatin—Renal failure—Doxorubicin—sarcoma	5.34e-05	0.000753	CcSEcCtD
Cisplatin—Neuropathy peripheral—Doxorubicin—sarcoma	5.32e-05	0.000751	CcSEcCtD
Cisplatin—Stomatitis—Doxorubicin—sarcoma	5.29e-05	0.000746	CcSEcCtD
Cisplatin—Body temperature increased—Etoposide—sarcoma	5.28e-05	0.000744	CcSEcCtD
Cisplatin—Conjunctivitis—Doxorubicin—sarcoma	5.28e-05	0.000744	CcSEcCtD
Cisplatin—MPO—C-MYB transcription factor network—MYC—sarcoma	5.26e-05	0.0017	CbGpPWpGaD
Cisplatin—MPO—Folate Metabolism—TP53—sarcoma	5.24e-05	0.00169	CbGpPWpGaD
Cisplatin—Vomiting—Vincristine—sarcoma	5.24e-05	0.000739	CcSEcCtD
Cisplatin—Urinary tract disorder—Epirubicin—sarcoma	5.2e-05	0.000734	CcSEcCtD
Cisplatin—Rash—Vincristine—sarcoma	5.2e-05	0.000733	CcSEcCtD
Cisplatin—Dermatitis—Vincristine—sarcoma	5.19e-05	0.000732	CcSEcCtD
Cisplatin—Connective tissue disorder—Epirubicin—sarcoma	5.18e-05	0.00073	CcSEcCtD
Cisplatin—ABCG2—lymph node—sarcoma	5.17e-05	0.00126	CbGeAlD
Cisplatin—Urethral disorder—Epirubicin—sarcoma	5.16e-05	0.000728	CcSEcCtD
Cisplatin—Hepatobiliary disease—Doxorubicin—sarcoma	5.13e-05	0.000724	CcSEcCtD
Cisplatin—PTGS2—Calcium signaling in the CD4+ TCR pathway—IL2—sarcoma	5.12e-05	0.00165	CbGpPWpGaD
Cisplatin—Vomiting—Mitoxantrone—sarcoma	5.1e-05	0.00072	CcSEcCtD
Cisplatin—Visual impairment—Epirubicin—sarcoma	5.08e-05	0.000716	CcSEcCtD
Cisplatin—Rash—Mitoxantrone—sarcoma	5.06e-05	0.000714	CcSEcCtD
Cisplatin—Dermatitis—Mitoxantrone—sarcoma	5.06e-05	0.000713	CcSEcCtD
Cisplatin—ABCG2—HIF-2-alpha transcription factor network—VEGFA—sarcoma	5.02e-05	0.00162	CbGpPWpGaD
Cisplatin—ATP7A—Cellular responses to stress—JUN—sarcoma	4.98e-05	0.00161	CbGpPWpGaD
Cisplatin—PTGS2—Calcium signaling in the CD4+ TCR pathway—JUN—sarcoma	4.98e-05	0.00161	CbGpPWpGaD
Cisplatin—Bradycardia—Doxorubicin—sarcoma	4.96e-05	0.0007	CcSEcCtD
Cisplatin—Eye disorder—Epirubicin—sarcoma	4.92e-05	0.000694	CcSEcCtD
Cisplatin—Hypersensitivity—Etoposide—sarcoma	4.92e-05	0.000694	CcSEcCtD
Cisplatin—Tinnitus—Epirubicin—sarcoma	4.91e-05	0.000693	CcSEcCtD
Cisplatin—Nausea—Vincristine—sarcoma	4.89e-05	0.00069	CcSEcCtD
Cisplatin—Cardiac disorder—Epirubicin—sarcoma	4.89e-05	0.000689	CcSEcCtD
Cisplatin—Flushing—Epirubicin—sarcoma	4.89e-05	0.000689	CcSEcCtD
Cisplatin—MPO—C-MYB transcription factor network—KRAS—sarcoma	4.86e-05	0.00157	CbGpPWpGaD
Cisplatin—GSTM1—C-MYB transcription factor network—HRAS—sarcoma	4.86e-05	0.00157	CbGpPWpGaD
Cisplatin—ABCB1—uterus—sarcoma	4.85e-05	0.00118	CbGeAlD
Cisplatin—SOD1—Hemostasis—PLCG1—sarcoma	4.82e-05	0.00155	CbGpPWpGaD
Cisplatin—Urinary tract disorder—Doxorubicin—sarcoma	4.81e-05	0.000679	CcSEcCtD
Cisplatin—Asthenia—Etoposide—sarcoma	4.79e-05	0.000675	CcSEcCtD
Cisplatin—Connective tissue disorder—Doxorubicin—sarcoma	4.79e-05	0.000675	CcSEcCtD
Cisplatin—Urethral disorder—Doxorubicin—sarcoma	4.78e-05	0.000674	CcSEcCtD
Cisplatin—Nausea—Mitoxantrone—sarcoma	4.77e-05	0.000672	CcSEcCtD
Cisplatin—Immune system disorder—Epirubicin—sarcoma	4.76e-05	0.000671	CcSEcCtD
Cisplatin—Mediastinal disorder—Epirubicin—sarcoma	4.75e-05	0.000669	CcSEcCtD
Cisplatin—ABCB1—HIF-1-alpha transcription factor network—CXCR4—sarcoma	4.75e-05	0.00153	CbGpPWpGaD
Cisplatin—Arrhythmia—Epirubicin—sarcoma	4.71e-05	0.000664	CcSEcCtD
Cisplatin—ABCG2—HIF-1-alpha transcription factor network—CREB1—sarcoma	4.7e-05	0.00152	CbGpPWpGaD
Cisplatin—Visual impairment—Doxorubicin—sarcoma	4.7e-05	0.000662	CcSEcCtD
Cisplatin—Alopecia—Epirubicin—sarcoma	4.65e-05	0.000656	CcSEcCtD
Cisplatin—MT2A—Cytokine Signaling in Immune system—IL2—sarcoma	4.6e-05	0.00148	CbGpPWpGaD
Cisplatin—Malnutrition—Epirubicin—sarcoma	4.58e-05	0.000647	CcSEcCtD
Cisplatin—Erythema—Epirubicin—sarcoma	4.58e-05	0.000647	CcSEcCtD
Cisplatin—Diarrhoea—Etoposide—sarcoma	4.57e-05	0.000644	CcSEcCtD
Cisplatin—Eye disorder—Doxorubicin—sarcoma	4.55e-05	0.000642	CcSEcCtD
Cisplatin—Tinnitus—Doxorubicin—sarcoma	4.54e-05	0.000641	CcSEcCtD
Cisplatin—Cardiac disorder—Doxorubicin—sarcoma	4.52e-05	0.000638	CcSEcCtD
Cisplatin—Flushing—Doxorubicin—sarcoma	4.52e-05	0.000638	CcSEcCtD
Cisplatin—Flatulence—Epirubicin—sarcoma	4.52e-05	0.000637	CcSEcCtD
Cisplatin—ABCB1—lymphoid tissue—sarcoma	4.52e-05	0.0011	CbGeAlD
Cisplatin—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—PDGFRB—sarcoma	4.44e-05	0.00143	CbGpPWpGaD
Cisplatin—Muscle spasms—Epirubicin—sarcoma	4.41e-05	0.000622	CcSEcCtD
Cisplatin—Immune system disorder—Doxorubicin—sarcoma	4.4e-05	0.000621	CcSEcCtD
Cisplatin—Mediastinal disorder—Doxorubicin—sarcoma	4.39e-05	0.000619	CcSEcCtD
Cisplatin—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—PDGFRA—sarcoma	4.37e-05	0.00141	CbGpPWpGaD
Cisplatin—ATP7A—Cellular responses to stress—VEGFA—sarcoma	4.35e-05	0.00141	CbGpPWpGaD
Cisplatin—Arrhythmia—Doxorubicin—sarcoma	4.35e-05	0.000614	CcSEcCtD
Cisplatin—Vision blurred—Epirubicin—sarcoma	4.32e-05	0.000609	CcSEcCtD
Cisplatin—Alopecia—Doxorubicin—sarcoma	4.31e-05	0.000607	CcSEcCtD
Cisplatin—PTGS2—Signaling mediated by p38-alpha and p38-beta—JUN—sarcoma	4.28e-05	0.00138	CbGpPWpGaD
Cisplatin—Ill-defined disorder—Epirubicin—sarcoma	4.25e-05	0.0006	CcSEcCtD
Cisplatin—Vomiting—Etoposide—sarcoma	4.24e-05	0.000599	CcSEcCtD
Cisplatin—Malnutrition—Doxorubicin—sarcoma	4.24e-05	0.000598	CcSEcCtD
Cisplatin—Erythema—Doxorubicin—sarcoma	4.24e-05	0.000598	CcSEcCtD
Cisplatin—Anaemia—Epirubicin—sarcoma	4.24e-05	0.000598	CcSEcCtD
Cisplatin—Rash—Etoposide—sarcoma	4.21e-05	0.000594	CcSEcCtD
Cisplatin—Dermatitis—Etoposide—sarcoma	4.2e-05	0.000593	CcSEcCtD
Cisplatin—Flatulence—Doxorubicin—sarcoma	4.18e-05	0.00059	CcSEcCtD
Cisplatin—Malaise—Epirubicin—sarcoma	4.13e-05	0.000583	CcSEcCtD
Cisplatin—MPO—C-MYB transcription factor network—HRAS—sarcoma	4.13e-05	0.00133	CbGpPWpGaD
Cisplatin—PTGS2—lymph node—sarcoma	4.12e-05	0.001	CbGeAlD
Cisplatin—ABCB1—bone marrow—sarcoma	4.11e-05	0.001	CbGeAlD
Cisplatin—Leukopenia—Epirubicin—sarcoma	4.1e-05	0.000579	CcSEcCtD
Cisplatin—Muscle spasms—Doxorubicin—sarcoma	4.08e-05	0.000575	CcSEcCtD
Cisplatin—MT2A—Immune System—PTPRC—sarcoma	4.03e-05	0.0013	CbGpPWpGaD
Cisplatin—Vision blurred—Doxorubicin—sarcoma	4e-05	0.000564	CcSEcCtD
Cisplatin—Convulsion—Epirubicin—sarcoma	3.97e-05	0.00056	CcSEcCtD
Cisplatin—Nausea—Etoposide—sarcoma	3.97e-05	0.000559	CcSEcCtD
Cisplatin—MT2A—Immune System—PLCG1—sarcoma	3.95e-05	0.00127	CbGpPWpGaD
Cisplatin—Ill-defined disorder—Doxorubicin—sarcoma	3.94e-05	0.000555	CcSEcCtD
Cisplatin—Anaemia—Doxorubicin—sarcoma	3.92e-05	0.000553	CcSEcCtD
Cisplatin—PTGS2—Integrated Pancreatic Cancer Pathway—WT1—sarcoma	3.91e-05	0.00126	CbGpPWpGaD
Cisplatin—Myalgia—Epirubicin—sarcoma	3.9e-05	0.000551	CcSEcCtD
Cisplatin—Anxiety—Epirubicin—sarcoma	3.89e-05	0.000549	CcSEcCtD
Cisplatin—ABCG2—Fluoropyrimidine Activity—TP53—sarcoma	3.89e-05	0.00125	CbGpPWpGaD
Cisplatin—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—sarcoma	3.88e-05	0.000547	CcSEcCtD
Cisplatin—MT2A—Cytokine Signaling in Immune system—NRAS—sarcoma	3.86e-05	0.00124	CbGpPWpGaD
Cisplatin—Discomfort—Epirubicin—sarcoma	3.86e-05	0.000544	CcSEcCtD
Cisplatin—Malaise—Doxorubicin—sarcoma	3.83e-05	0.00054	CcSEcCtD
Cisplatin—Leukopenia—Doxorubicin—sarcoma	3.8e-05	0.000536	CcSEcCtD
Cisplatin—MT2A—Immune System—ATF1—sarcoma	3.75e-05	0.00121	CbGpPWpGaD
Cisplatin—Anaphylactic shock—Epirubicin—sarcoma	3.74e-05	0.000528	CcSEcCtD
Cisplatin—Oedema—Epirubicin—sarcoma	3.74e-05	0.000528	CcSEcCtD
Cisplatin—Infection—Epirubicin—sarcoma	3.72e-05	0.000524	CcSEcCtD
Cisplatin—Convulsion—Doxorubicin—sarcoma	3.68e-05	0.000518	CcSEcCtD
Cisplatin—Nervous system disorder—Epirubicin—sarcoma	3.67e-05	0.000518	CcSEcCtD
Cisplatin—GSTT1—Metabolism—ENO2—sarcoma	3.67e-05	0.00118	CbGpPWpGaD
Cisplatin—Thrombocytopenia—Epirubicin—sarcoma	3.66e-05	0.000517	CcSEcCtD
Cisplatin—Tachycardia—Epirubicin—sarcoma	3.65e-05	0.000515	CcSEcCtD
Cisplatin—GSTT1—Metabolism—HBA1—sarcoma	3.64e-05	0.00118	CbGpPWpGaD
Cisplatin—Skin disorder—Epirubicin—sarcoma	3.63e-05	0.000513	CcSEcCtD
Cisplatin—Hyperhidrosis—Epirubicin—sarcoma	3.62e-05	0.00051	CcSEcCtD
Cisplatin—Myalgia—Doxorubicin—sarcoma	3.61e-05	0.000509	CcSEcCtD
Cisplatin—Anxiety—Doxorubicin—sarcoma	3.6e-05	0.000508	CcSEcCtD
Cisplatin—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—sarcoma	3.59e-05	0.000506	CcSEcCtD
Cisplatin—Discomfort—Doxorubicin—sarcoma	3.57e-05	0.000503	CcSEcCtD
Cisplatin—Anorexia—Epirubicin—sarcoma	3.57e-05	0.000503	CcSEcCtD
Cisplatin—SOD1—Platelet activation, signaling and aggregation—IL2—sarcoma	3.56e-05	0.00115	CbGpPWpGaD
Cisplatin—ABCB1—testis—sarcoma	3.52e-05	0.000855	CbGeAlD
Cisplatin—Hypotension—Epirubicin—sarcoma	3.5e-05	0.000493	CcSEcCtD
Cisplatin—Oedema—Doxorubicin—sarcoma	3.46e-05	0.000488	CcSEcCtD
Cisplatin—Anaphylactic shock—Doxorubicin—sarcoma	3.46e-05	0.000488	CcSEcCtD
Cisplatin—SOD1—Cellular responses to stress—MDM2—sarcoma	3.45e-05	0.00111	CbGpPWpGaD
Cisplatin—ABCG2—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—sarcoma	3.45e-05	0.00111	CbGpPWpGaD
Cisplatin—Infection—Doxorubicin—sarcoma	3.44e-05	0.000485	CcSEcCtD
Cisplatin—Musculoskeletal discomfort—Epirubicin—sarcoma	3.41e-05	0.000481	CcSEcCtD
Cisplatin—Nervous system disorder—Doxorubicin—sarcoma	3.4e-05	0.000479	CcSEcCtD
Cisplatin—Thrombocytopenia—Doxorubicin—sarcoma	3.39e-05	0.000478	CcSEcCtD
Cisplatin—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—KIT—sarcoma	3.39e-05	0.00109	CbGpPWpGaD
Cisplatin—ABCG2—HIF-1-alpha transcription factor network—JUN—sarcoma	3.38e-05	0.00109	CbGpPWpGaD
Cisplatin—Tachycardia—Doxorubicin—sarcoma	3.38e-05	0.000477	CcSEcCtD
Cisplatin—Skin disorder—Doxorubicin—sarcoma	3.36e-05	0.000474	CcSEcCtD
Cisplatin—Paraesthesia—Epirubicin—sarcoma	3.36e-05	0.000474	CcSEcCtD
Cisplatin—Hyperhidrosis—Doxorubicin—sarcoma	3.35e-05	0.000472	CcSEcCtD
Cisplatin—Dyspnoea—Epirubicin—sarcoma	3.34e-05	0.000471	CcSEcCtD
Cisplatin—ABCB1—liver—sarcoma	3.32e-05	0.000808	CbGeAlD
Cisplatin—MT2A—Cytokine Signaling in Immune system—KRAS—sarcoma	3.32e-05	0.00107	CbGpPWpGaD
Cisplatin—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—IL2—sarcoma	3.31e-05	0.00107	CbGpPWpGaD
Cisplatin—Anorexia—Doxorubicin—sarcoma	3.3e-05	0.000465	CcSEcCtD
Cisplatin—ATP7A—Cellular responses to stress—TP53—sarcoma	3.29e-05	0.00106	CbGpPWpGaD
Cisplatin—Decreased appetite—Epirubicin—sarcoma	3.25e-05	0.000459	CcSEcCtD
Cisplatin—Hypotension—Doxorubicin—sarcoma	3.24e-05	0.000456	CcSEcCtD
Cisplatin—Gastrointestinal disorder—Epirubicin—sarcoma	3.23e-05	0.000456	CcSEcCtD
Cisplatin—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—JUN—sarcoma	3.22e-05	0.00104	CbGpPWpGaD
Cisplatin—Pain—Epirubicin—sarcoma	3.2e-05	0.000451	CcSEcCtD
Cisplatin—Musculoskeletal discomfort—Doxorubicin—sarcoma	3.15e-05	0.000445	CcSEcCtD
Cisplatin—GSTT1—Metabolism—PLCG1—sarcoma	3.11e-05	0.001	CbGpPWpGaD
Cisplatin—Paraesthesia—Doxorubicin—sarcoma	3.11e-05	0.000438	CcSEcCtD
Cisplatin—PTGS2—C-MYB transcription factor network—KIT—sarcoma	3.11e-05	0.001	CbGpPWpGaD
Cisplatin—SOD1—Platelet activation, signaling and aggregation—SRC—sarcoma	3.1e-05	0.001	CbGpPWpGaD
Cisplatin—PTGS2—Aryl Hydrocarbon Receptor—SRC—sarcoma	3.09e-05	0.000996	CbGpPWpGaD
Cisplatin—Dyspnoea—Doxorubicin—sarcoma	3.09e-05	0.000435	CcSEcCtD
Cisplatin—Feeling abnormal—Epirubicin—sarcoma	3.08e-05	0.000435	CcSEcCtD
Cisplatin—BCHE—Peptide hormone metabolism—CTNNB1—sarcoma	3.04e-05	0.00098	CbGpPWpGaD
Cisplatin—SOD1—Platelet activation, signaling and aggregation—VEGFA—sarcoma	3.02e-05	0.000975	CbGpPWpGaD
Cisplatin—GSTP1—Cellular responses to stress—MDM2—sarcoma	3.01e-05	0.000972	CbGpPWpGaD
Cisplatin—Decreased appetite—Doxorubicin—sarcoma	3.01e-05	0.000424	CcSEcCtD
Cisplatin—PTGS2—Aryl Hydrocarbon Receptor—VEGFA—sarcoma	3.01e-05	0.00097	CbGpPWpGaD
Cisplatin—SOD1—Cellular responses to stress—JUN—sarcoma	3e-05	0.000968	CbGpPWpGaD
Cisplatin—Gastrointestinal disorder—Doxorubicin—sarcoma	2.99e-05	0.000422	CcSEcCtD
Cisplatin—ABCB1—Allograft Rejection—PDGFRA—sarcoma	2.98e-05	0.000962	CbGpPWpGaD
Cisplatin—PTGS2—Aryl Hydrocarbon Receptor—NRAS—sarcoma	2.97e-05	0.000958	CbGpPWpGaD
Cisplatin—Pain—Doxorubicin—sarcoma	2.96e-05	0.000418	CcSEcCtD
Cisplatin—Body temperature increased—Epirubicin—sarcoma	2.96e-05	0.000417	CcSEcCtD
Cisplatin—ABCG2—HIF-1-alpha transcription factor network—VEGFA—sarcoma	2.95e-05	0.000953	CbGpPWpGaD
Cisplatin—Feeling abnormal—Doxorubicin—sarcoma	2.85e-05	0.000402	CcSEcCtD
Cisplatin—PTGS2—Signaling mediated by p38-alpha and p38-beta—TP53—sarcoma	2.83e-05	0.000912	CbGpPWpGaD
Cisplatin—MT2A—Cytokine Signaling in Immune system—HRAS—sarcoma	2.82e-05	0.000911	CbGpPWpGaD
Cisplatin—MT2A—Immune System—FOXO1—sarcoma	2.8e-05	0.000903	CbGpPWpGaD
Cisplatin—MT2A—Immune System—PDGFRB—sarcoma	2.79e-05	0.000902	CbGpPWpGaD
Cisplatin—ABCB1—Integrated Pancreatic Cancer Pathway—WT1—sarcoma	2.77e-05	0.000895	CbGpPWpGaD
Cisplatin—PTGS2—Aryl Hydrocarbon Receptor—MYC—sarcoma	2.77e-05	0.000893	CbGpPWpGaD
Cisplatin—Hypersensitivity—Epirubicin—sarcoma	2.76e-05	0.000389	CcSEcCtD
Cisplatin—MT2A—Immune System—PDGFRA—sarcoma	2.75e-05	0.000888	CbGpPWpGaD
Cisplatin—Body temperature increased—Doxorubicin—sarcoma	2.74e-05	0.000386	CcSEcCtD
Cisplatin—PTGS2—Aryl Hydrocarbon Receptor—EGFR—sarcoma	2.71e-05	0.000873	CbGpPWpGaD
Cisplatin—Asthenia—Epirubicin—sarcoma	2.68e-05	0.000379	CcSEcCtD
Cisplatin—SOD1—Cellular responses to stress—VEGFA—sarcoma	2.62e-05	0.000846	CbGpPWpGaD
Cisplatin—GSTP1—Cellular responses to stress—JUN—sarcoma	2.62e-05	0.000845	CbGpPWpGaD
Cisplatin—ABCC5—Disease—TLE1—sarcoma	2.57e-05	0.00083	CbGpPWpGaD
Cisplatin—Diarrhoea—Epirubicin—sarcoma	2.56e-05	0.000361	CcSEcCtD
Cisplatin—PTGS2—Aryl Hydrocarbon Receptor—KRAS—sarcoma	2.56e-05	0.000825	CbGpPWpGaD
Cisplatin—Hypersensitivity—Doxorubicin—sarcoma	2.55e-05	0.00036	CcSEcCtD
Cisplatin—ABCB1—lymph node—sarcoma	2.55e-05	0.00062	CbGeAlD
Cisplatin—ABCB1—HIF-1-alpha transcription factor network—CREB1—sarcoma	2.54e-05	0.00082	CbGpPWpGaD
Cisplatin—Asthenia—Doxorubicin—sarcoma	2.48e-05	0.00035	CcSEcCtD
Cisplatin—Vomiting—Epirubicin—sarcoma	2.38e-05	0.000336	CcSEcCtD
Cisplatin—Diarrhoea—Doxorubicin—sarcoma	2.37e-05	0.000334	CcSEcCtD
Cisplatin—GSTM1—Metabolism—ENO2—sarcoma	2.36e-05	0.000762	CbGpPWpGaD
Cisplatin—Rash—Epirubicin—sarcoma	2.36e-05	0.000333	CcSEcCtD
Cisplatin—Dermatitis—Epirubicin—sarcoma	2.36e-05	0.000332	CcSEcCtD
Cisplatin—GSTM1—Metabolism—HBA1—sarcoma	2.35e-05	0.000758	CbGpPWpGaD
Cisplatin—ABCC5—Disease—NPM1—sarcoma	2.32e-05	0.000749	CbGpPWpGaD
Cisplatin—GSTP1—Cellular responses to stress—VEGFA—sarcoma	2.29e-05	0.000738	CbGpPWpGaD
Cisplatin—Nausea—Epirubicin—sarcoma	2.22e-05	0.000313	CcSEcCtD
Cisplatin—Vomiting—Doxorubicin—sarcoma	2.2e-05	0.00031	CcSEcCtD
Cisplatin—Rash—Doxorubicin—sarcoma	2.18e-05	0.000308	CcSEcCtD
Cisplatin—Dermatitis—Doxorubicin—sarcoma	2.18e-05	0.000308	CcSEcCtD
Cisplatin—PTGS2—Aryl Hydrocarbon Receptor—HRAS—sarcoma	2.17e-05	0.000701	CbGpPWpGaD
Cisplatin—BCHE—Transmission across Chemical Synapses—CREB1—sarcoma	2.15e-05	0.000692	CbGpPWpGaD
Cisplatin—MT2A—Immune System—KIT—sarcoma	2.13e-05	0.000688	CbGpPWpGaD
Cisplatin—PTGS2—C-MYB transcription factor network—CCND1—sarcoma	2.13e-05	0.000688	CbGpPWpGaD
Cisplatin—PTGS2—Integrated Pancreatic Cancer Pathway—PDGFRA—sarcoma	2.08e-05	0.00067	CbGpPWpGaD
Cisplatin—Nausea—Doxorubicin—sarcoma	2.06e-05	0.00029	CcSEcCtD
Cisplatin—MT2A—Immune System—CREB1—sarcoma	2.03e-05	0.000655	CbGpPWpGaD
Cisplatin—ABCC5—Disease—ENO2—sarcoma	2.01e-05	0.000649	CbGpPWpGaD
Cisplatin—GSTP1—Metabolism—ENO2—sarcoma	2.01e-05	0.000648	CbGpPWpGaD
Cisplatin—GSTM1—Metabolism—PLCG1—sarcoma	2e-05	0.000647	CbGpPWpGaD
Cisplatin—GSTP1—Metabolism—HBA1—sarcoma	2e-05	0.000644	CbGpPWpGaD
Cisplatin—SOD1—Cellular responses to stress—TP53—sarcoma	1.98e-05	0.000639	CbGpPWpGaD
Cisplatin—NQO1—Metabolism—ENO2—sarcoma	1.96e-05	0.000632	CbGpPWpGaD
Cisplatin—NQO1—Metabolism—HBA1—sarcoma	1.95e-05	0.000628	CbGpPWpGaD
Cisplatin—SLC22A2—Transmission across Chemical Synapses—CREB1—sarcoma	1.92e-05	0.000618	CbGpPWpGaD
Cisplatin—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—sarcoma	1.86e-05	0.000602	CbGpPWpGaD
Cisplatin—PTGS2—C-MYB transcription factor network—NRAS—sarcoma	1.83e-05	0.000592	CbGpPWpGaD
Cisplatin—SOD1—Hemostasis—IL2—sarcoma	1.83e-05	0.000591	CbGpPWpGaD
Cisplatin—ABCB1—HIF-1-alpha transcription factor network—JUN—sarcoma	1.83e-05	0.00059	CbGpPWpGaD
Cisplatin—BCHE—Transmission across Chemical Synapses—MDM2—sarcoma	1.78e-05	0.000573	CbGpPWpGaD
Cisplatin—XDH—Metabolism—ENO2—sarcoma	1.76e-05	0.000567	CbGpPWpGaD
Cisplatin—XDH—Metabolism—HBA1—sarcoma	1.74e-05	0.000563	CbGpPWpGaD
Cisplatin—GSTP1—Cellular responses to stress—TP53—sarcoma	1.73e-05	0.000558	CbGpPWpGaD
Cisplatin—PTGS2—C-MYB transcription factor network—MYC—sarcoma	1.71e-05	0.000551	CbGpPWpGaD
Cisplatin—ABCC5—Disease—PLCG1—sarcoma	1.71e-05	0.00055	CbGpPWpGaD
Cisplatin—GSTP1—Metabolism—PLCG1—sarcoma	1.7e-05	0.00055	CbGpPWpGaD
Cisplatin—ABCC5—Metabolism—ENO2—sarcoma	1.68e-05	0.000543	CbGpPWpGaD
Cisplatin—MT2A—Immune System—MDM2—sarcoma	1.68e-05	0.000542	CbGpPWpGaD
Cisplatin—ABCC5—Metabolism—HBA1—sarcoma	1.67e-05	0.00054	CbGpPWpGaD
Cisplatin—PTGS2—Spinal Cord Injury—IL2—sarcoma	1.67e-05	0.000537	CbGpPWpGaD
Cisplatin—NQO1—Metabolism—PLCG1—sarcoma	1.66e-05	0.000536	CbGpPWpGaD
Cisplatin—BCHE—Neuronal System—CREB1—sarcoma	1.64e-05	0.000531	CbGpPWpGaD
Cisplatin—ABCC5—Disease—CXCR4—sarcoma	1.64e-05	0.000529	CbGpPWpGaD
Cisplatin—ABCB1—Allograft Rejection—IL2—sarcoma	1.63e-05	0.000525	CbGpPWpGaD
Cisplatin—PTGS2—Spinal Cord Injury—CCND1—sarcoma	1.62e-05	0.000524	CbGpPWpGaD
Cisplatin—SOD1—Hemostasis—SRC—sarcoma	1.6e-05	0.000516	CbGpPWpGaD
Cisplatin—ABCB1—HIF-1-alpha transcription factor network—VEGFA—sarcoma	1.6e-05	0.000515	CbGpPWpGaD
Cisplatin—SLC22A2—Transmission across Chemical Synapses—MDM2—sarcoma	1.59e-05	0.000512	CbGpPWpGaD
Cisplatin—PTGS2—C-MYB transcription factor network—KRAS—sarcoma	1.58e-05	0.00051	CbGpPWpGaD
Cisplatin—SOD1—Hemostasis—VEGFA—sarcoma	1.56e-05	0.000503	CbGpPWpGaD
Cisplatin—SOD1—Hemostasis—NRAS—sarcoma	1.54e-05	0.000497	CbGpPWpGaD
Cisplatin—PTGS2—Integrated Pancreatic Cancer Pathway—CREB1—sarcoma	1.53e-05	0.000494	CbGpPWpGaD
Cisplatin—MT2A—Immune System—IL2—sarcoma	1.5e-05	0.000484	CbGpPWpGaD
Cisplatin—XDH—Metabolism—PLCG1—sarcoma	1.49e-05	0.000481	CbGpPWpGaD
Cisplatin—ABCB1—Integrated Pancreatic Cancer Pathway—PDGFRA—sarcoma	1.47e-05	0.000475	CbGpPWpGaD
Cisplatin—SLC22A2—Neuronal System—CREB1—sarcoma	1.47e-05	0.000474	CbGpPWpGaD
Cisplatin—MT2A—Immune System—JUN—sarcoma	1.46e-05	0.000471	CbGpPWpGaD
Cisplatin—CYP4A11—Metabolism—ENO2—sarcoma	1.46e-05	0.000471	CbGpPWpGaD
Cisplatin—CYP4A11—Metabolism—HBA1—sarcoma	1.45e-05	0.000468	CbGpPWpGaD
Cisplatin—MT2A—Immune System—CTNNB1—sarcoma	1.45e-05	0.000468	CbGpPWpGaD
Cisplatin—ABCC5—Metabolism—PLCG1—sarcoma	1.43e-05	0.000461	CbGpPWpGaD
Cisplatin—ABCB1—Allograft Rejection—VEGFA—sarcoma	1.38e-05	0.000446	CbGpPWpGaD
Cisplatin—BCHE—Neuronal System—MDM2—sarcoma	1.36e-05	0.000439	CbGpPWpGaD
Cisplatin—PTGS2—C-MYB transcription factor network—HRAS—sarcoma	1.34e-05	0.000433	CbGpPWpGaD
Cisplatin—SOD1—Hemostasis—KRAS—sarcoma	1.32e-05	0.000427	CbGpPWpGaD
Cisplatin—MT2A—Immune System—SRC—sarcoma	1.31e-05	0.000423	CbGpPWpGaD
Cisplatin—PTGS2—Spinal Cord Injury—MYC—sarcoma	1.3e-05	0.00042	CbGpPWpGaD
Cisplatin—PTGS2—Spinal Cord Injury—EGFR—sarcoma	1.27e-05	0.000411	CbGpPWpGaD
Cisplatin—PTGS2—Integrated Pancreatic Cancer Pathway—MDM2—sarcoma	1.27e-05	0.000409	CbGpPWpGaD
Cisplatin—MT2A—Immune System—NRAS—sarcoma	1.26e-05	0.000407	CbGpPWpGaD
Cisplatin—ABCC3—Metabolism—ENO2—sarcoma	1.24e-05	0.0004	CbGpPWpGaD
Cisplatin—CYP4A11—Metabolism—PLCG1—sarcoma	1.24e-05	0.0004	CbGpPWpGaD
Cisplatin—ABCC3—Metabolism—HBA1—sarcoma	1.23e-05	0.000398	CbGpPWpGaD
Cisplatin—SLC22A2—Neuronal System—MDM2—sarcoma	1.21e-05	0.000392	CbGpPWpGaD
Cisplatin—ABCC5—Disease—FOXO1—sarcoma	1.21e-05	0.00039	CbGpPWpGaD
Cisplatin—ABCC5—Disease—PDGFRB—sarcoma	1.21e-05	0.00039	CbGpPWpGaD
Cisplatin—ABCC5—Disease—PDGFRA—sarcoma	1.19e-05	0.000384	CbGpPWpGaD
Cisplatin—SOD1—Hemostasis—TP53—sarcoma	1.18e-05	0.00038	CbGpPWpGaD
Cisplatin—MT2A—Immune System—EGFR—sarcoma	1.15e-05	0.00037	CbGpPWpGaD
Cisplatin—SOD1—Hemostasis—HRAS—sarcoma	1.13e-05	0.000363	CbGpPWpGaD
Cisplatin—PTGS2—Integrated Pancreatic Cancer Pathway—CCND1—sarcoma	1.1e-05	0.000356	CbGpPWpGaD
Cisplatin—PTGS2—Integrated Pancreatic Cancer Pathway—JUN—sarcoma	1.1e-05	0.000356	CbGpPWpGaD
Cisplatin—PTGS2—Integrated Pancreatic Cancer Pathway—CTNNB1—sarcoma	1.09e-05	0.000353	CbGpPWpGaD
Cisplatin—ABCB1—Integrated Pancreatic Cancer Pathway—CREB1—sarcoma	1.09e-05	0.000351	CbGpPWpGaD
Cisplatin—MT2A—Immune System—KRAS—sarcoma	1.08e-05	0.00035	CbGpPWpGaD
Cisplatin—PTGS2—Spinal Cord Injury—TP53—sarcoma	1.07e-05	0.000345	CbGpPWpGaD
Cisplatin—ABCC3—Metabolism—PLCG1—sarcoma	1.05e-05	0.00034	CbGpPWpGaD
Cisplatin—PTGS2—Disease—TLE1—sarcoma	9.97e-06	0.000322	CbGpPWpGaD
Cisplatin—PTGS2—Integrated Pancreatic Cancer Pathway—SRC—sarcoma	9.89e-06	0.000319	CbGpPWpGaD
Cisplatin—BCHE—Transmission across Chemical Synapses—HRAS—sarcoma	9.74e-06	0.000314	CbGpPWpGaD
Cisplatin—PTGS2—Integrated Pancreatic Cancer Pathway—VEGFA—sarcoma	9.63e-06	0.000311	CbGpPWpGaD
Cisplatin—BCHE—Metabolism—ENO2—sarcoma	9.48e-06	0.000306	CbGpPWpGaD
Cisplatin—BCHE—Metabolism—HBA1—sarcoma	9.42e-06	0.000304	CbGpPWpGaD
Cisplatin—ABCC5—Disease—KIT—sarcoma	9.22e-06	0.000298	CbGpPWpGaD
Cisplatin—MT2A—Immune System—HRAS—sarcoma	9.22e-06	0.000297	CbGpPWpGaD
Cisplatin—PTGS2—Disease—NPM1—sarcoma	9e-06	0.00029	CbGpPWpGaD
Cisplatin—ABCB1—Integrated Pancreatic Cancer Pathway—MDM2—sarcoma	8.99e-06	0.00029	CbGpPWpGaD
Cisplatin—PTGS2—Integrated Pancreatic Cancer Pathway—MYC—sarcoma	8.86e-06	0.000286	CbGpPWpGaD
Cisplatin—ABCC5—Disease—CREB1—sarcoma	8.78e-06	0.000283	CbGpPWpGaD
Cisplatin—SLC22A2—Transmission across Chemical Synapses—HRAS—sarcoma	8.7e-06	0.000281	CbGpPWpGaD
Cisplatin—PTGS2—Integrated Pancreatic Cancer Pathway—EGFR—sarcoma	8.66e-06	0.00028	CbGpPWpGaD
Cisplatin—ABCG2—Metabolism—ENO2—sarcoma	8.56e-06	0.000276	CbGpPWpGaD
Cisplatin—ABCG2—Metabolism—HBA1—sarcoma	8.5e-06	0.000274	CbGpPWpGaD
Cisplatin—SLC22A2—Metabolism—ENO2—sarcoma	8.47e-06	0.000273	CbGpPWpGaD
Cisplatin—SLC22A2—Metabolism—HBA1—sarcoma	8.42e-06	0.000272	CbGpPWpGaD
Cisplatin—PTGS2—Integrated Pancreatic Cancer Pathway—KRAS—sarcoma	8.19e-06	0.000264	CbGpPWpGaD
Cisplatin—BCHE—Metabolism—PLCG1—sarcoma	8.05e-06	0.00026	CbGpPWpGaD
Cisplatin—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—sarcoma	7.83e-06	0.000253	CbGpPWpGaD
Cisplatin—ABCB1—Integrated Pancreatic Cancer Pathway—JUN—sarcoma	7.81e-06	0.000252	CbGpPWpGaD
Cisplatin—PTGS2—Disease—ENO2—sarcoma	7.79e-06	0.000251	CbGpPWpGaD
Cisplatin—ABCB1—Integrated Pancreatic Cancer Pathway—CTNNB1—sarcoma	7.75e-06	0.00025	CbGpPWpGaD
Cisplatin—BCHE—Metabolism of proteins—MMP2—sarcoma	7.48e-06	0.000241	CbGpPWpGaD
Cisplatin—BCHE—Neuronal System—HRAS—sarcoma	7.46e-06	0.000241	CbGpPWpGaD
Cisplatin—PTGS2—Integrated Pancreatic Cancer Pathway—TP53—sarcoma	7.27e-06	0.000235	CbGpPWpGaD
Cisplatin—ABCC5—Disease—MDM2—sarcoma	7.26e-06	0.000234	CbGpPWpGaD
Cisplatin—ABCG2—Metabolism—PLCG1—sarcoma	7.26e-06	0.000234	CbGpPWpGaD
Cisplatin—SLC22A2—Metabolism—PLCG1—sarcoma	7.19e-06	0.000232	CbGpPWpGaD
Cisplatin—ABCB1—Integrated Pancreatic Cancer Pathway—SRC—sarcoma	7.01e-06	0.000226	CbGpPWpGaD
Cisplatin—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—sarcoma	6.82e-06	0.00022	CbGpPWpGaD
Cisplatin—SLC22A2—Neuronal System—HRAS—sarcoma	6.67e-06	0.000215	CbGpPWpGaD
Cisplatin—PTGS2—Disease—PLCG1—sarcoma	6.61e-06	0.000213	CbGpPWpGaD
Cisplatin—PTGS2—Metabolism—ENO2—sarcoma	6.53e-06	0.000211	CbGpPWpGaD
Cisplatin—PTGS2—Metabolism—HBA1—sarcoma	6.49e-06	0.000209	CbGpPWpGaD
Cisplatin—PTGS2—Disease—CXCR4—sarcoma	6.35e-06	0.000205	CbGpPWpGaD
Cisplatin—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—sarcoma	6.28e-06	0.000203	CbGpPWpGaD
Cisplatin—CYP2B6—Metabolism—ENO2—sarcoma	6.27e-06	0.000202	CbGpPWpGaD
Cisplatin—ABCC5—Disease—CTNNB1—sarcoma	6.26e-06	0.000202	CbGpPWpGaD
Cisplatin—CYP2B6—Metabolism—HBA1—sarcoma	6.23e-06	0.000201	CbGpPWpGaD
Cisplatin—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—sarcoma	6.14e-06	0.000198	CbGpPWpGaD
Cisplatin—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—sarcoma	5.8e-06	0.000187	CbGpPWpGaD
Cisplatin—BCHE—Metabolism of proteins—CTNNB1—sarcoma	5.73e-06	0.000185	CbGpPWpGaD
Cisplatin—ABCC5—Disease—SRC—sarcoma	5.66e-06	0.000183	CbGpPWpGaD
Cisplatin—PTGS2—Metabolism—PLCG1—sarcoma	5.54e-06	0.000179	CbGpPWpGaD
Cisplatin—ABCC5—Disease—NRAS—sarcoma	5.45e-06	0.000176	CbGpPWpGaD
Cisplatin—CYP2B6—Metabolism—PLCG1—sarcoma	5.32e-06	0.000172	CbGpPWpGaD
Cisplatin—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—sarcoma	5.16e-06	0.000166	CbGpPWpGaD
Cisplatin—ABCC5—Disease—MYC—sarcoma	5.07e-06	0.000164	CbGpPWpGaD
Cisplatin—ABCC5—Disease—EGFR—sarcoma	4.96e-06	0.00016	CbGpPWpGaD
Cisplatin—PTGS2—Disease—FOXO1—sarcoma	4.69e-06	0.000151	CbGpPWpGaD
Cisplatin—ABCC5—Disease—KRAS—sarcoma	4.69e-06	0.000151	CbGpPWpGaD
Cisplatin—PTGS2—Disease—PDGFRB—sarcoma	4.68e-06	0.000151	CbGpPWpGaD
Cisplatin—ABCB1—Metabolism—ENO2—sarcoma	4.63e-06	0.000149	CbGpPWpGaD
Cisplatin—PTGS2—Disease—PDGFRA—sarcoma	4.61e-06	0.000149	CbGpPWpGaD
Cisplatin—ABCB1—Metabolism—HBA1—sarcoma	4.6e-06	0.000148	CbGpPWpGaD
Cisplatin—CYP2C9—Metabolism—ENO2—sarcoma	4.32e-06	0.000139	CbGpPWpGaD
Cisplatin—CYP2C9—Metabolism—HBA1—sarcoma	4.29e-06	0.000139	CbGpPWpGaD
Cisplatin—ABCC5—Disease—HRAS—sarcoma	3.99e-06	0.000129	CbGpPWpGaD
Cisplatin—ABCB1—Metabolism—PLCG1—sarcoma	3.93e-06	0.000127	CbGpPWpGaD
Cisplatin—CYP2C9—Metabolism—PLCG1—sarcoma	3.67e-06	0.000118	CbGpPWpGaD
Cisplatin—PTGS2—Disease—KIT—sarcoma	3.57e-06	0.000115	CbGpPWpGaD
Cisplatin—PTGS2—Disease—CREB1—sarcoma	3.4e-06	0.00011	CbGpPWpGaD
Cisplatin—PTGS2—Disease—MDM2—sarcoma	2.82e-06	9.08e-05	CbGpPWpGaD
Cisplatin—PTGS2—Disease—CTNNB1—sarcoma	2.43e-06	7.84e-05	CbGpPWpGaD
Cisplatin—PTGS2—Disease—SRC—sarcoma	2.2e-06	7.08e-05	CbGpPWpGaD
Cisplatin—PTGS2—Disease—NRAS—sarcoma	2.11e-06	6.81e-05	CbGpPWpGaD
Cisplatin—PTGS2—Disease—MYC—sarcoma	1.97e-06	6.35e-05	CbGpPWpGaD
Cisplatin—PTGS2—Disease—EGFR—sarcoma	1.92e-06	6.21e-05	CbGpPWpGaD
Cisplatin—PTGS2—Disease—KRAS—sarcoma	1.82e-06	5.86e-05	CbGpPWpGaD
Cisplatin—PTGS2—Disease—HRAS—sarcoma	1.54e-06	4.98e-05	CbGpPWpGaD
